APAC Self-Monitoring Blood Glucose Devices Market to exceed $4bn by 2024: Medtronic, Nipro Diagnostics, Nova Biomedical, Sinocare and Trividia Health

APAC Self-Monitoring Blood Glucose Devices Market size is set to surpass USD 4 billion by 2024. Rising prevalence of obesity in highly populated countries such as India and China will be a major factor that will drive the self-monitoring blood glucose devices market during the forecast period. Increasing cases of obesity leading to type II diabetes will increase the demand for SMBG devices in the region. Growing geriatric population base will further act as primary driver for growth of Asia Pacific self-monitoring blood glucose devices market during the forecast period.

The research report “Asia Pacific Self-Monitoring Blood Glucose Devices Market analysis based on Product, End-User, Industry Analysis Report, Regional Outlook, End-User Potential, Competitive Market Share & Forecast, 2018 – 2024” by Graphical Research.

Request for a sample of this research report - https://www.graphicalresearch.com/request/1013/sample

Several efforts undertaken by government and other organizations to increase awareness pertaining to diabetes management will accelerate SMBG devices market growth. National Program for Prevention and Control of Diabetes organized by Ministry of Health and Family Welfare, Diabetes Foundation of India and International Diabetes Federation (IDF) Diabetes Program focusing on reducing the burden of prediabetes by providing appropriate diabetes education to patients as well as healthcare providers will escalate the adoption of SMBG devices, thereby propelling industry growth.

Advancements in technology to develop novel glucose monitoring devices coupled with availability of portable, user-friendly and accurate SMBG devices will increase the adoption of such advanced devices. However, prohibitive costs associated with self-monitoring blood glucose devices and their accessories may hinder industry expansion in the foreseeable future. Stringent regulations and poor reimbursement scenario should impede the industry growth in near future.

Continuous glucose monitors segment is estimated to witness lucrative growth of 6.8% during the forecast period. Demand for continuous glucose monitoring devices is high in patients that require continuous monitoring. CGM systems monitor blood glucose levels every 5 minutes or at frequent intervals. Increasing adoption of such devices in ICU patients or in hospital settings will foster the segmental growth during the forecast period.

Browse key industry insights from this 2018 report @
https://www.graphicalresearch.com/industry-insights/1013/asia-pacific-self-monitoring-blood-glucose-devices-market

Hospitals segment accounted for USD 1.3 billion in 2017 and is anticipated to show significant growth over the analysis timeframe. The growth is attributable to the increasing incidence of hypo and hyperglycemia among patients. Ability of hospitals to buy advanced and costly devices, well-developed infrastructure as well as availability of skilled technicians will further drive segmental growth in the coming years.

China self-monitoring blood glucose devices market accounted for USD 743.3 million revenue in 2017 and is estimated to witness robust growth over the forecast period. China being highly populous country comprises of large population base suffering from diabetes. Increasing prevalence of diabetes as well as growing elderly population will augment industry growth over the analysis timeframe.

Some of the notable players operating in Asia Pacific self-monitoring blood glucose devices market include Abbott Laboratories, All Medicus, Arkray, B. Braun Melsungen AG, Bayer Healthcare, Bionime Corporation, Dexcom, F. Hoffmann-La Roche, Johnson & Johnson, LifeScan, Medtronic, Nipro Diagnostics, Nova Biomedical, Sinocare and Trividia Health. Market players are focusing on new product development, acquisitions and mergers to broaden product portfolio as well as widen company’s customer base.

Make an inquiry for purchasing this report @ https://www.graphicalresearch.com/request/1013/inquiry-before-buying

Segments We Cover:

Asia Pacific Self-Monitoring Blood Glucose Devices Market Statistics, by Product
Self-monitoring blood glucose meters, Continuous glucose monitors, Testing strips, Lancets

Asia Pacific Self-Monitoring Blood Glucose Devices Market Trends, By End-user
Hospitals, Home settings, Diagnostic centers and clinics

The above information is provided for the following countries:
China, Japan, India, Australia, South Korea, Malaysia, Indonesia, Thailand, Singapore, Taiwan, Philippines, Vietnam, Others

About Graphical Research:

Graphical Research is a business research firm that provides industry insights, market forecast and strategic inputs through granular research reports and advisory services. We publish targeted research reports with an aim to address varied customer needs, from market penetration and entry strategies to portfolio management and strategic outlook. We understand that business requirements are unique: our syndicate reports are designed to ensure relevance for industry participants across the value chain. We also provide custom reports that are tailored to the exact needs of the customer, with dedicated analyst support across the purchase lifecycle.

Contact Us:

Parikhit B.
Corporate sales,
Graphical Research
Email: sales@graphicalresearh.com
Web: https://www.graphicalresearch.com/

This release was published on openPR.